StockOrNot
Open the deck

Cigna (CI)

Health Care · $77.9B market cap · SEC CIK 0001739940

$303.13 ▲+2.55% on the day close of Nov 10, 2026
53 Mixed
ahead of 53% of the S&P 500 · #29 of 59 in Health Care

Next reports on Feb 3, 2027, after the close, with analysts expecting $7.49 in earnings per share.

52-week range $255.53 to $318.05. 5% below its 52-week high and 19% above its low.

The case for CI

The case against

What the score is made of

Each factor is half a curve over reported figures and half a rank among the other Health Care companies (momentum is judged against fixed thresholds only), and the five are blended by weight. The score is where that blend places it in the S&P 500. It describes the last filing and the current price. It is not a forecast.

Valuewhat you pay for the earnings and cash, against the growth you get73
Growthhow fast revenue and earnings are moving, this year and over five46
Profitabilityhow much of the revenue becomes profit, and how much of that is cash33
Momentumhow the price has behaved lately67
Stabilityhow violently it moves, what it owes and what it pays you75

The financials

Revenue growth

Is the business growing? Slowly

Last 12 months+6.8%
Over 5 years+11.4% a year
FY2025 revenue$275B (+11%)

Free cash flow

Is it generating real cash? Can't tell: no capital spending in its filings

FY2025 operating cash flow$9.6B
Of profit, before capital spending161%

Its filings do not give capital spending, so free cash flow cannot be worked out. Operating cash flow, which is before that spending, is shown instead, and the score judges it against a stricter bar.

Profit margins

Is profitability improving? Holding steady

Gross margin9%
Operating margin3%
Net margin, FY24 → FY25 → now1.4% → 2.2% → 2.1%

Debt vs. cash

Is the balance sheet healthy? Mostly, with some debt to carry

Cash$7.7B
Long-term debt$30.9B
Net debt$23.2B
Years to repay3.2 yrs

Valuation

Is the stock price reasonable? Yes, it looks cheap

P/E13.0×
Fair P/E for its growth19×
P/FCFn/a
Forward P/E9.1×
EV / EBITDA8.9×

At 13.0× earnings it trades below the 19× that 6% a year of growth plus a 1.7% dividend would justify.

The financials, five years deep

Pulled from Cigna's XBRL filings on SEC EDGAR. Italic rows are worked out from the others.

FY2025FY2024FY2023FY2022FY2021
Revenue growth
Revenue$275B$247B$195B$181B$174B
Change on the year+11%+27%+8%+4%—
Profit margins
Operating margin3.3%3.8%4.4%4.7%4.6%
Net margin2.2%1.4%2.6%3.8%3.1%
Debt vs. cash
Cash$7.7B$7.5B$7.8B$5.9B$5.1B
Long-term debt$30.9B$28.9B$28.2B$28.1B$31.1B
Net cash (debt)−$23.2B−$21.4B−$20.3B−$22.2B−$26.0B

What Cigna says it does

OVERVIEW The Cigna Group ® , together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company. Our Focused Mission The Cigna Group is a global health company committed to creating a better future for every individual and every community. Powered by our dedicated people and valued brands, we advance our mission to improve the health and vitality of those we serve by staying grounded in the needs of our customers and patients - delivering a personalized, transparent and affordable health care experience. We focus on leading the way to partner and innovate solutions for better health. At The Cigna Group our global workforce of approximately 67,700 colleagues strives to fulfill our mission to improve the health and vitality of more than 185 million customer relationships in more than 30 markets and jurisdictions (as of December 31, 2025). We play an important…

Risk factors CI lists in its 10-K

Filings

Open CI in the deck

Other Health Care companies

LLYEli LillyJNJJohnson & JohnsonABBVAbbVieMRKMerck & Co.UNHUnitedHealth GroupTMOThermo Fisher ScientificAMGNAmgenGILDGilead SciencesABTAbbott LaboratoriesPFEPfizerDHRDanaherISRGIntuitive Surgical